Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| ChemoCentryx commences CCX168 Phase II trial to treat Vasculitis - Pharmaceutical Business Review |
 |
 |
|
Pharmaceutical Business Review ChemoCentryx has commenced the Phase II clinical trial for CCX168, an orally-administered small molecule used to treat anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), a disease that can cause renal and pulmonary failure. ... ChemoCentryx Initiates Phase II Clinical Trial for CCX168, a Novel Small |
